Lemaitre Vascular Inc (LMAT)

$62.19

+1.51

(+2.49%)

Market is closed - opens 8 PM, 26 Feb 2024

Insights on Lemaitre Vascular Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 50.11M → 47.41M (in $), with an average decrease of 5.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 8.09M → 7.50M (in $), with an average decrease of 7.4% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 68.7% return, outperforming this stock by 47.4%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 57.6% return, outperforming this stock by 23.7%

Performance

  • $60.19
    $62.36
    $62.19
    downward going graph

    3.22%

    Downside

    Day's Volatility :3.48%

    Upside

    0.27%

    downward going graph
  • $44.03
    $68.13
    $62.19
    downward going graph

    29.2%

    Downside

    52 Weeks Volatility :35.37%

    Upside

    8.72%

    downward going graph

Returns

PeriodLemaitre Vascular IncSector (Health Care)Index (Russel 2000)
3 Months
16.57%
12.8%
0.0%
6 Months
9.74%
10.8%
0.0%
1 Year
26.58%
15.1%
-6.4%
3 Years
33.89%
30.2%
-19.6%

Highlights

Market Capitalization
1.4B
Book Value
$12.97
Dividend Share
0.545
Dividend Yield
0.92%
Earnings Per Share (EPS)
1.22
PE Ratio
49.74
PEG Ratio
2.9
Wall Street Target Price
63.38
Profit Margin
14.69%
Operating Margin TTM
19.36%
Return On Assets TTM
6.67%
Return On Equity TTM
9.92%
Revenue TTM
185.6M
Revenue Per Share TTM
8.38
Quarterly Revenue Growth YOY
21.5%
Gross Profit TTM
104.9M
EBITDA
43.3M
Diluted Eps TTM
1.22
Quarterly Earnings Growth YOY
0.33
EPS Estimate Current Year
1.33
EPS Estimate Next Year
1.53
EPS Estimate Current Quarter
0.3
EPS Estimate Next Quarter
0.34

Analyst Recommendation

Buy
    71%Buy
    28%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Lemaitre Vascular Inc(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
9
9
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1.91%

Current $62.19
Target $63.38

Company Financials

FY18Y/Y Change
Revenue
105.6M
↑ 4.66%
Net Income
22.9M
↑ 33.57%
Net Profit Margin
21.73%
↑ 4.7%
FY19Y/Y Change
Revenue
117.2M
↑ 11.05%
Net Income
17.9M
↓ 21.83%
Net Profit Margin
15.3%
↓ 6.43%
FY20Y/Y Change
Revenue
129.4M
↑ 10.35%
Net Income
21.2M
↑ 18.32%
Net Profit Margin
16.4%
↑ 1.1%
FY21Y/Y Change
Revenue
154.4M
↑ 19.37%
Net Income
26.9M
↑ 26.8%
Net Profit Margin
17.42%
↑ 1.02%
FY22Y/Y Change
Revenue
161.7M
↑ 4.68%
Net Income
20.6M
↓ 23.31%
Net Profit Margin
12.77%
↓ 4.65%
FY23Y/Y Change
Revenue
185.6M
↑ 14.79%
Net Income
27.3M
↑ 32.13%
Net Profit Margin
14.69%
↑ 1.92%
Q2 FY22Q/Q Change
Revenue
42.1M
↑ 6.44%
Net Income
3.5M
↓ 41.79%
Net Profit Margin
8.35%
↓ 6.91%
Q3 FY22Q/Q Change
Revenue
39.0M
↓ 7.31%
Net Income
5.5M
↑ 55.22%
Net Profit Margin
13.98%
↑ 5.63%
Q4 FY22Q/Q Change
Revenue
41.0M
↑ 4.93%
Net Income
5.6M
↑ 3.13%
Net Profit Margin
13.74%
↓ 0.24%
Q1 FY23Q/Q Change
Revenue
47.1M
↑ 14.95%
Net Income
6.0M
↑ 7.34%
Net Profit Margin
12.83%
↓ 0.91%
Q2 FY23Q/Q Change
Revenue
50.1M
↑ 6.46%
Net Income
8.1M
↑ 34.07%
Net Profit Margin
16.16%
↑ 3.33%
Q3 FY23Q/Q Change
Revenue
47.4M
↓ 5.4%
Net Income
7.5M
↓ 7.36%
Net Profit Margin
15.82%
↓ 0.34%
FY17Y/Y Change
Total Assets
126.3M
↑ 23.94%
Total Liabilities
16.6M
↑ 14.76%
FY18Y/Y Change
Total Assets
153.1M
↑ 21.19%
Total Liabilities
22.9M
↑ 38.06%
FY19Y/Y Change
Total Assets
188.3M
↑ 23.03%
Total Liabilities
40.2M
↑ 75.89%
FY20Y/Y Change
Total Assets
252.8M
↑ 34.23%
Total Liabilities
80.2M
↑ 99.62%
FY21Y/Y Change
Total Assets
292.8M
↑ 15.82%
Total Liabilities
38.7M
↓ 51.83%
FY22Y/Y Change
Total Assets
310.5M
↑ 6.04%
Total Liabilities
42.3M
↑ 9.38%
Q2 FY22Q/Q Change
Total Assets
299.4M
↑ 2.38%
Total Liabilities
41.4M
↑ 19.4%
Q3 FY22Q/Q Change
Total Assets
302.0M
↑ 0.88%
Total Liabilities
40.8M
↓ 1.43%
Q4 FY22Q/Q Change
Total Assets
310.5M
↑ 2.79%
Total Liabilities
42.3M
↑ 3.61%
Q1 FY23Q/Q Change
Total Assets
314.9M
↑ 1.41%
Total Liabilities
40.7M
↓ 3.72%
Q2 FY23Q/Q Change
Total Assets
326.5M
↑ 3.68%
Total Liabilities
42.6M
↑ 4.76%
Q3 FY23Q/Q Change
Total Assets
334.0M
↑ 2.31%
Total Liabilities
45.4M
↑ 6.41%
FY18Y/Y Change
Operating Cash Flow
19.5M
↓ 14.7%
Investing Cash Flow
-7.1M
↓ 75.64%
Financing Cash Flow
-4.4M
↓ 5620.0%
FY19Y/Y Change
Operating Cash Flow
14.2M
↓ 27.31%
Investing Cash Flow
-24.1M
↑ 241.6%
Financing Cash Flow
-4.6M
↑ 4.66%
FY20Y/Y Change
Operating Cash Flow
34.8M
↑ 145.43%
Investing Cash Flow
-52.9M
↑ 119.46%
Financing Cash Flow
32.2M
↓ 795.69%
FY21Y/Y Change
Operating Cash Flow
35.1M
↑ 0.87%
Investing Cash Flow
-61.1M
↑ 15.48%
Financing Cash Flow
13.7M
↓ 57.39%
FY22Y/Y Change
Operating Cash Flow
25.4M
↓ 27.7%
Investing Cash Flow
-10.4M
↓ 83.02%
Financing Cash Flow
-9.2M
↓ 167.39%
Q2 FY22Q/Q Change
Operating Cash Flow
9.2M
↑ 96.31%
Investing Cash Flow
-973.0K
↑ 81.53%
Financing Cash Flow
-2.6M
↑ 8.61%
Q3 FY22Q/Q Change
Operating Cash Flow
7.3M
↓ 20.61%
Investing Cash Flow
-8.5M
↑ 769.48%
Financing Cash Flow
-2.1M
↓ 16.94%
Q4 FY22Q/Q Change
Operating Cash Flow
4.1M
↓ 44.47%
Investing Cash Flow
-402.0K
↓ 95.25%
Financing Cash Flow
-2.1M
↓ 1.16%
Q1 FY23Q/Q Change
Operating Cash Flow
2.3M
↓ 44.1%
Investing Cash Flow
-3.0M
↑ 637.31%
Financing Cash Flow
-1.8M
↓ 14.0%
Q2 FY23Q/Q Change
Operating Cash Flow
11.9M
↑ 422.29%
Investing Cash Flow
-9.6M
↑ 225.2%
Financing Cash Flow
502.0K
↓ 127.51%

Technicals Summary

Sell

Neutral

Buy

Lemaitre Vascular Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lemaitre Vascular Inc
Lemaitre Vascular Inc
8.19%
9.74%
26.58%
33.89%
107.23%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
3.95%
30.99%
68.19%
57.63%
111.3%
Resmed Inc.
Resmed Inc.
-1.24%
14.32%
-13.14%
-5.61%
81.03%
Becton, Dickinson And Company
Becton, Dickinson And Company
4.07%
-12.07%
3.93%
-0.38%
-1.63%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
3.73%
-6.68%
17.41%
32.32%
249.58%
Alcon Ag
Alcon Ag
4.93%
-4.68%
13.26%
14.42%
37.94%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lemaitre Vascular Inc
Lemaitre Vascular Inc
49.74
49.74
2.9
1.33
0.1
0.07
0.01
12.97
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
77.51
77.51
5.71
6.25
0.15
0.08
NA
37.77
Resmed Inc.
Resmed Inc.
30.31
30.31
1.88
7.45
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
55.88
55.88
1.34
12.94
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
45.67
45.67
9.06
7.61
0.21
0.12
0.0
39.2
Alcon Ag
Alcon Ag
87.9
87.9
1.09
2.74
0.02
0.02
0.0
40.86
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lemaitre Vascular Inc
Lemaitre Vascular Inc
Buy
$1.4B
107.23%
49.74
14.69%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$137.1B
111.3%
77.51
25.24%
Resmed Inc.
Resmed Inc.
Buy
$26.9B
81.03%
30.31
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$70.4B
-1.63%
55.88
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$26.4B
249.58%
45.67
20.12%
Alcon Ag
Alcon Ag
Buy
$39.3B
37.94%
87.9
4.85%

Institutional Holdings

  • BlackRock Inc

    14.70%
  • Conestoga Capital Advisors, LLC

    8.66%
  • Vanguard Group Inc

    6.79%
  • Copeland Capital Management, LLC

    5.66%
  • Ranger Investment Management LP

    4.10%
  • Geneva Capital Management

    4.06%

Corporate Announcements

  • Lemaitre Vascular Inc Dividends March,2023

    In the quarter ending March,2023. Lemaitre Vascular Inc has declared dividend of $0.14

    Read More

Company Information

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Organization
Lemaitre Vascular Inc
Employees
591
CEO
Mr. George W. LeMaitre
Industry
Health Technology

FAQs